This study is in progress, not accepting new patients
Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS)
Summary
- Eligibility
- for males ages 6 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Jay Stewart
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Jay Stewart
Professor, Ophthalmology. Authored (or co-authored) 121 research publications.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Applied Genetic Technologies Corp
- Links
- AGTC website
- ID
- NCT02416622
- Phase
- Phase 1/2
- Study Type
- Interventional
- Last Updated